Key result
Heart-specific deletion of lipoprotein lipase in mice subjected to hypertensive stress resulted in cardiac energy deficiency and progression to heart failure, unlike control mice which developed compensated hypertrophy.
Why the study?
Does heart-specific lipoprotein lipase knockout impair cardiac metabolic compensation and lead to heart failure in mice with induced hypertension?
Does heart-specific lipoprotein lipase knockout impair cardiac metabolic compensation and lead to heart failure in mice with induced hypertension?
Lipoprotein lipase activity is essential for normal cardiac metabolic compensation and the prevention of heart failure during hypertensive stress in a murine model.
No takes yet. Share an insight, caveat, or question.
Suggests metabolic targets for preventing HF decompensation; leaves open translation from murine models to clinical practice.
Yamashita et al. (2008) studied Hypertension-induced cardiac hypertrophy and heart failure. Heart-specific lipoprotein lipase knockout (hLpL0) during induced hypertension vs. Control mice with induced hypertension was evaluated on Development of heart failure and cardiac metabolic changes (ATP content, fractional shortening). Heart-specific deletion of lipoprotein lipase in mice subjected to hypertensive stress resulted in cardiac energy deficiency and progression to heart failure, unlike control mice which developed compensated hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: